Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  HIV Infection

  Free Subscription


Articles published in HIV Med

Retrieve available abstracts of 207 articles:
HTML format
Text format



Single Articles


    May 2018
  1. GUO F, Cheng X, Hsieh E, Du X, et al
    Prospective plasma efavirenz concentration assessment in Chinese HIV-infected adults enrolled in a large multicentre study.
    HIV Med. 2018 May 15. doi: 10.1111/hiv.12607.
    PubMed     Text format     Abstract available


  2. TRUNFIO M, Vai D, Montrucchio C, Alcantarini C, et al
    Diagnostic accuracy of new and old cognitive screening tools for HIV-associated neurocognitive disorders.
    HIV Med. 2018 May 15. doi: 10.1111/hiv.12622.
    PubMed     Text format     Abstract available


  3. AHMED SI, Hasan SS, Babar MG
    Patients' involvement in the care process: time to value nontraditional indicators in HIV care.
    HIV Med. 2018 May 10. doi: 10.1111/hiv.12620.
    PubMed     Text format    


  4. GONZALEZ-CORDON A, Domenech M, Camafort M, Martinez-Rebollar M, et al
    Subclinical cardiovascular disease in patients starting contemporary protease inhibitors.
    HIV Med. 2018 May 10. doi: 10.1111/hiv.12619.
    PubMed     Text format     Abstract available


  5. CROXFORD S, Yin Z, Kall M, Burns F, et al
    Where do we diagnose HIV infection? Monitoring new diagnoses made in nontraditional settings in England, Wales and Northern Ireland.
    HIV Med. 2018 May 9. doi: 10.1111/hiv.12627.
    PubMed     Text format     Abstract available


  6. JAKOBSEN SF, Raben D, Sperle I, Lazarus JV, et al
    Scale-up of HIV self-testing.
    HIV Med. 2018 May 8. doi: 10.1111/hiv.12618.
    PubMed     Text format    


  7. BROWN AE, Attawell K, Hales D, Rice BD, et al
    Monitoring the HIV continuum of care in key populations across Europe and Central Asia.
    HIV Med. 2018 May 8. doi: 10.1111/hiv.12603.
    PubMed     Text format     Abstract available


    April 2018
  8. CRESSWELL FV, Ellis J, Hartley J, Sabin CA, et al
    A systematic review of risk of HIV transmission through biting or spitting: implications for policy.
    HIV Med. 2018 Apr 23. doi: 10.1111/hiv.12625.
    PubMed     Text format     Abstract available


  9. JIAMSAKUL A, Yunihastuti E, Van Nguyen K, Merati TP, et al
    Mortality following diagnosis of tuberculosis in HIV-infected patients in Asia.
    HIV Med. 2018 Apr 23. doi: 10.1111/hiv.12621.
    PubMed     Text format    


  10. MASIA M, Padilla S, Garcia JA, Bernardino JI, et al
    Decreasing rates of acute myocardial infarction in people living with HIV: a nationwide cohort study in Spain, 2004-2015.
    HIV Med. 2018 Apr 23. doi: 10.1111/hiv.12616.
    PubMed     Text format     Abstract available


  11. GOMPELS M, Michael S, Jose S, Hill T, et al
    The use of funnel plots with regression as a tool to visually compare HIV treatment outcomes between centres adjusting for patient characteristics and size: a UK Collaborative HIV Cohort study.
    HIV Med. 2018 Apr 14. doi: 10.1111/hiv.12604.
    PubMed     Text format     Abstract available



  12. Abstracts of the 4th Joint Conference of the British HIV Association (BHIVA) with the British Association for Sexual Health and HIV (BASHH), Edinburgh, UK, 17-20 April 2018.
    HIV Med. 2018;19 Suppl 2:s5-s152.
    PubMed     Text format    


    March 2018
  13. DAUBY N, Martin C, Hainaut M, Grammens T, et al
    Prevalence and risk factors of measles seronegativity in a cohort of HIV-positive subjects: a retrospective study.
    HIV Med. 2018 Mar 24. doi: 10.1111/hiv.12610.
    PubMed     Text format     Abstract available


  14. AEBI-POPP K, Wandeler G, Salazar-Vizcaya L, Metzner K, et al
    Rapid decline of anti-hepatitis C virus (HCV) antibodies following early treatment of incident HCV infections in HIV-infected men who have sex with men.
    HIV Med. 2018 Mar 24. doi: 10.1111/hiv.12602.
    PubMed     Text format     Abstract available


  15. BORGHETTI A, Baldin G, Lombardi F, Ciccullo A, et al
    Efficacy and tolerability of lamivudine plus dolutegravir as a switch strategy in a multicentre cohort of patients with suppressed HIV-1 replication.
    HIV Med. 2018 Mar 24. doi: 10.1111/hiv.12611.
    PubMed     Text format     Abstract available


  16. NIMKAR S, Valvi C, Kadam D, Rewari BB, et al
    Loss to follow-up and mortality among HIV-infected adolescents receiving antiretroviral therapy in Pune, India.
    HIV Med. 2018 Mar 24. doi: 10.1111/hiv.12605.
    PubMed     Text format     Abstract available


  17. SEZGIN E, Van Natta ML, Thorne JE, Puhan MA, et al
    Secular trends in opportunistic infections, cancers and mortality in patients with AIDS during the era of modern combination antiretroviral therapy.
    HIV Med. 2018 Mar 24. doi: 10.1111/hiv.12609.
    PubMed     Text format     Abstract available


  18. HONGE BL, Jespersen S, Medina C, Te DS, et al
    The challenge of discriminating between HIV-1, HIV-2 and HIV-1/2 dual infections.
    HIV Med. 2018 Mar 24. doi: 10.1111/hiv.12606.
    PubMed     Text format     Abstract available


  19. RYOM L, Boesecke C, Bracchi M, Ambrosioni J, et al
    Highlights of the 2017 European AIDS Clinical Society (EACS) Guidelines for the treatment of adult HIV-positive persons version 9.0.
    HIV Med. 2018 Mar 1. doi: 10.1111/hiv.12600.
    PubMed     Text format     Abstract available


    February 2018
  20. OPREA C, Ianache I, Calistru PI, Nica M, et al
    Increasing incidence of HIV- associated tuberculosis in Romanian injecting drug users.
    HIV Med. 2018 Feb 21. doi: 10.1111/hiv.12576.
    PubMed     Text format     Abstract available


  21. HAYNES BI, Pitkanen M, Kulasegaram R, Casey SJ, et al
    HIV: ageing, cognition and neuroimaging at 4-year follow-up.
    HIV Med. 2018 Feb 14. doi: 10.1111/hiv.12598.
    PubMed     Text format     Abstract available


  22. SANTOS JR, Cozzi-Lepri A, Phillips A, De Wit S, et al
    Long-term effectiveness of recommended boosted protease inhibitor-based antiretroviral therapy in Europe.
    HIV Med. 2018 Feb 1. doi: 10.1111/hiv.12581.
    PubMed     Text format     Abstract available


  23. ASPINALL EJ, Hutchinson SJ, Goldberg DJ, Valerio H, et al
    Monitoring response to hepatitis B and C in EU/EEA: testing policies, availability of data on care cascade and chronic viral hepatitis-related mortality - results from two surveys (2016).
    HIV Med. 2018;19 Suppl 1:11-15.
    PubMed     Text format     Abstract available


  24. RABEN D, Hoekstra M, Sperle I, Amato Gauci AJ, et al
    The HepHIV 2017 Conference in Malta: joining forces for the earlier diagnosis of HIV and viral hepatitis.
    HIV Med. 2018;19 Suppl 1:5-10.
    PubMed     Text format     Abstract available


  25. MEULBROEK M, Pujol F, Perez F, Dalmau-Bueno A, et al
    BCN Checkpoint: same-day confirmation of reactive HIV rapid test with Point Of Care HIV-RNA accelerates linkage to care and reduces anxiety.
    HIV Med. 2018;19 Suppl 1:63-65.
    PubMed     Text format     Abstract available


  26. POWER L, Hows J, Jakobsen SF
    Key findings on legal and regulatory barriers to HIV testing and access to care across Europe.
    HIV Med. 2018;19 Suppl 1:58-62.
    PubMed     Text format     Abstract available


  27. ANAGNOSTOU O, Fotiou A, Kanavou E, Antaraki A, et al
    Factors associated with HCV test uptake in heroin users entering substitution treatment in Greece.
    HIV Med. 2018;19 Suppl 1:34-39.
    PubMed     Text format     Abstract available


  28. SCHWEITZER AM, Bogdan M, Corduneanu A, Ciocea I, et al
    Role of pretest counseling sessions on increasing subjective knowledge about HIV and hepatitis transmission among the beneficiaries of a free of charge, voluntary counseling and testing program in Constanta, Romania.
    HIV Med. 2018;19 Suppl 1:66-70.
    PubMed     Text format     Abstract available


  29. CROXFORD S, Burns F, Copas A, Pharris A, et al
    Factors associated with delayed linkage to care following HIV diagnosis in the WHO European Region.
    HIV Med. 2018;19 Suppl 1:40-46.
    PubMed     Text format     Abstract available


  30. FERNANDEZ-LOPEZ L, Reyes-Uruena J, Agusti C, Kustec T, et al
    The COBATEST network: monitoring and evaluation of HIV community-based practices in Europe, 2014-2016.
    HIV Med. 2018;19 Suppl 1:21-26.
    PubMed     Text format     Abstract available


  31. RUUTEL K, Lemsalu L, Latt S
    Monitoring HIV-indicator condition guided HIV testing in Estonia.
    HIV Med. 2018;19 Suppl 1:47-51.
    PubMed     Text format     Abstract available


  32. HOYOS J, Mate T, Indave BI, Agusti C, et al
    Knowledge, actual and potential use of HIV self-sampling testing kits among MSM recruited in eight European countries.
    HIV Med. 2018;19 Suppl 1:27-33.
    PubMed     Text format     Abstract available


  33. PLATTEAU T, van Lankveld J, Apers L, Fransen K, et al
    HIV testing for key populations in Europe: A decade of technological innovation and patient empowerment complement the role of health care professionals.
    HIV Med. 2018;19 Suppl 1:71-76.
    PubMed     Text format     Abstract available


  34. RUUTEL K, Kallavus K, Tomera I
    Monitoring anonymous HIV testing in Estonia from 2005 to 2015.
    HIV Med. 2018;19 Suppl 1:16-20.
    PubMed     Text format     Abstract available


  35. BRADSHAW D, Rae C, Rayment M, Turner N, et al
    HIV/HCV/HBV testing in the emergency department: a feasibility and seroprevalence study.
    HIV Med. 2018;19 Suppl 1:52-57.
    PubMed     Text format     Abstract available


    January 2018
  36. CICCULLO A, Gagliardini R, Baldin G, Borghetti A, et al
    An outbreak of acute hepatitis A among young adult men: clinical features and HIV coinfection rate from a large teaching hospital in Rome, Italy.
    HIV Med. 2018 Jan 29. doi: 10.1111/hiv.12597.
    PubMed     Text format     Abstract available


  37. BISCHOFF J, Mauss S, Cordes C, Lutz T, et al
    Rates of sustained virological response 12 weeks after the scheduled end of direct-acting antiviral (DAA)-based hepatitis C virus (HCV) therapy from the National German HCV registry: does HIV coinfection impair the response to DAA combination therapy?
    HIV Med. 2018 Jan 25. doi: 10.1111/hiv.12579.
    PubMed     Text format     Abstract available


  38. KRENTZ HB, Campbell S, Gill VC, Gill MJ, et al
    Patient perspectives on de-simplifying their single-tablet co-formulated antiretroviral therapy for societal cost savings.
    HIV Med. 2018 Jan 25. doi: 10.1111/hiv.12578.
    PubMed     Text format     Abstract available


  39. DI CARLOFELICE M, Everitt A, Muir D, Winston A, et al
    Cerebrospinal fluid HIV RNA in persons living with HIV.
    HIV Med. 2018 Jan 25. doi: 10.1111/hiv.12594.
    PubMed     Text format     Abstract available


  40. LIU Z, Fang Q, Zuo J, Minhas V, et al
    The world-wide incidence of Kaposi's sarcoma in the HIV/AIDS era.
    HIV Med. 2018 Jan 25. doi: 10.1111/hiv.12584.
    PubMed     Text format     Abstract available


  41. PUFALL EL, Kall M, Shahmanesh M, Nardone A, et al
    Sexualized drug use ('chemsex') and high-risk sexual behaviours in HIV-positive men who have sex with men.
    HIV Med. 2018 Jan 24. doi: 10.1111/hiv.12574.
    PubMed     Text format     Abstract available


  42. KWAN N, Wong A, Fang Y, Wang Z, et al
    'Get an early check - Chrysanthemum tea': An outcome evaluation of a multimedia campaign promoting HIV testing among men who have sex with men in Hong Kong.
    HIV Med. 2018 Jan 24. doi: 10.1111/hiv.12583.
    PubMed     Text format     Abstract available


  43. KENT L, Amlani A, Vundavalli S, Ridha BH, et al
    Clinical use of brain magnetic resonance imaging for neurological symptoms in people living with HIV.
    HIV Med. 2018 Jan 19. doi: 10.1111/hiv.12580.
    PubMed     Text format    


  44. AEBI-POPP K, Mercanti V, Voide C, Nemeth J, et al
    Neglect of attention to reproductive health in women with HIV infection: contraceptive use and unintended pregnancies in the Swiss HIV Cohort Study.
    HIV Med. 2018 Jan 16. doi: 10.1111/hiv.12582.
    PubMed     Text format     Abstract available


  45. PETERS H, Thorne C, Tookey PA, Byrne L, et al
    National audit of perinatal HIV infections in the UK, 2006-2013: what lessons can be learnt?
    HIV Med. 2018 Jan 16. doi: 10.1111/hiv.12577.
    PubMed     Text format     Abstract available


    December 2017
  46. LAHER A, Ariefdien N, Etlouba Y
    HIV prevalence among first-presentation psychotic patients.
    HIV Med. 2017 Dec 28. doi: 10.1111/hiv.12575.
    PubMed     Text format     Abstract available


  47. ROEN A, Laut K, Pelchen-Matthews A, Borodulina E, et al
    Abacavir usage patterns and hypersensitivity reactions in the EuroSIDA cohort.
    HIV Med. 2017 Dec 22. doi: 10.1111/hiv.12573.
    PubMed     Text format     Abstract available


  48. ROSENTHAL E, Fougerou-Leurent C, Renault A, Carrieri MP, et al
    Efficacy, safety and patient-reported outcomes of ledipasvir/sofosbuvir in NS3/4A protease inhibitor-experienced individuals with hepatitis C virus genotype 1 and HIV coinfection with and without cirrhosis (ANRS HC31 SOFTRIH study).
    HIV Med. 2017 Dec 7. doi: 10.1111/hiv.12571.
    PubMed     Text format     Abstract available


  49. MUKANYANGEZI MF, Sengpiel V, Manzi O, Tobin G, et al
    Screening for human papillomavirus, cervical cytological abnormalities and associated risk factors in HIV-positive and HIV-negative women in Rwanda.
    HIV Med. 2017 Dec 6. doi: 10.1111/hiv.12564.
    PubMed     Text format     Abstract available


  50. BASHIR T, Reddy K
    HbAHP-25 attenuates HIV-1 gp120 mediated inflammation and barrier dysfunction.
    HIV Med. 2017 Dec 6. doi: 10.1111/hiv.12569.
    PubMed     Text format     Abstract available


  51. SMOLDERS EJ, Smit C, de Kanter C, Dofferhoff A, et al
    Management of drug interactions with direct-acting antivirals in Dutch HIV/hepatitis C virus-coinfected patients: adequate but not perfect.
    HIV Med. 2017 Dec 1. doi: 10.1111/hiv.12570.
    PubMed     Text format     Abstract available


  52. STIRRUP OT, Copas AJ, Phillips AN, Gill MJ, et al
    Predictors of CD4 cell recovery following initiation of antiretroviral therapy among HIV-1 positive patients with well-estimated dates of seroconversion.
    HIV Med. 2017 Dec 1. doi: 10.1111/hiv.12567.
    PubMed     Text format     Abstract available


    November 2017
  53. UTHAPPA CK, Allam RR, Pant R, Pal S, et al
    Pre-exposure prophylaxis: awareness, acceptability and risk compensation behaviour among men who have sex with men and the transgender population.
    HIV Med. 2017 Nov 27. doi: 10.1111/hiv.12572.
    PubMed     Text format     Abstract available


  54. ELGALIB A, Fidler S, Sabapathy K
    Hospital-based routine HIV testing in high-income countries: a systematic literature review.
    HIV Med. 2017 Nov 23. doi: 10.1111/hiv.12568.
    PubMed     Text format     Abstract available


  55. JAO J, Yu W, Patel K, Miller TL, et al
    Improvement in lipids after switch to boosted atazanavir or darunavir in children/adolescents with perinatally acquired HIV on older protease inhibitors: results from the Pediatric HIV/AIDS Cohort Study.
    HIV Med. 2017 Nov 21. doi: 10.1111/hiv.12566.
    PubMed     Text format     Abstract available


  56. KOWALSKA JD, Aebi-Popp K, Loutfy M, Post FA, et al
    Promoting high standards of care for women living with HIV: position statement from the Women Against Viruses in Europe Working Group.
    HIV Med. 2017 Nov 21. doi: 10.1111/hiv.12565.
    PubMed     Text format     Abstract available


  57. YOUNG J, Smith C, Teira R, Reiss P, et al
    Antiretroviral pill count and clinical outcomes in treatment-naive patients with HIV infection.
    HIV Med. 2017 Nov 6. doi: 10.1111/hiv.12562.
    PubMed     Text format     Abstract available


  58. HUFF H, Merchant AT, Lonn E, Pullenayegum E, et al
    Vitamin D and progression of carotid intima-media thickness in HIV-positive Canadians.
    HIV Med. 2017 Nov 6. doi: 10.1111/hiv.12563.
    PubMed     Text format     Abstract available


  59. AIBIBULA W, Cox J, Hamelin AM, Moodie E, et al
    Food insecurity may lead to incomplete HIV viral suppression and less immune reconstitution among HIV/hepatitis C virus-coinfected people.
    HIV Med. 2017 Nov 2. doi: 10.1111/hiv.12561.
    PubMed     Text format     Abstract available



  60. A note of thanks to referees for Volume 18, 2017.
    HIV Med. 2017;18:793-795.
    PubMed     Text format    


    October 2017
  61. DE WIT S, Battegay M, D'Arminio Monforte A, Lundgren JD, et al
    European AIDS Clinical Society Second Standard of Care Meeting, Brussels 16-17 November 2016: a summary.
    HIV Med. 2017 Oct 27. doi: 10.1111/hiv.12559.
    PubMed     Text format     Abstract available


  62. COZZI-LEPRI A, Zangerle R, Machala L, Zilmer K, et al
    Incidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based combination antiretroviral therapy regimens.
    HIV Med. 2017 Oct 6. doi: 10.1111/hiv.12557.
    PubMed     Text format     Abstract available


  63. FUREGATO M, Mitchell H, Ogaz D, Woodhall S, et al
    The role of frequent HIV testing in diagnosing HIV in men who have sex with men.
    HIV Med. 2017 Oct 6. doi: 10.1111/hiv.12558.
    PubMed     Text format     Abstract available


    September 2017
  64. GERETTI AM, Loutfy M, D'Arminio Monforte A, Latysheva I, et al
    Out of focus: tailoring the cascade of care to the needs of women living with HIV.
    HIV Med. 2017;18 Suppl 2:3-17.
    PubMed     Text format     Abstract available


    August 2017
  65. SHEPHERD L, Borges AH, Harvey R, Bower M, et al
    The extent of B-cell activation and dysfunction preceding lymphoma development in HIV-positive people.
    HIV Med. 2017 Aug 31. doi: 10.1111/hiv.12546.
    PubMed     Text format     Abstract available


  66. HOFFMANN C, Welz T, Sabranski M, Kolb M, et al
    Reply to Letter 'Morning dosing for dolutegravir-related insomnia and sleep disorders' by Capetti et al.
    HIV Med. 2017 Aug 29. doi: 10.1111/hiv.12539.
    PubMed     Text format    


  67. DE POKOMANDY A, Rouleau D, Lalonde R, Beauvais C, et al
    Argon plasma coagulation treatment of anal high-grade squamous intraepithelial lesions in men who have sex with men living with HIV: results of a 2-year prospective pilot study.
    HIV Med. 2017 Aug 23. doi: 10.1111/hiv.12544.
    PubMed     Text format     Abstract available


  68. CUZIN L, Yazdanpanah Y, Huleux T, Cotte L, et al
    No relationship between late HIV diagnosis and social deprivation in newly diagnosed patients in France.
    HIV Med. 2017 Aug 18. doi: 10.1111/hiv.12545.
    PubMed     Text format     Abstract available


  69. KAMAL S, Bugnon O, Cavassini M, Schneider MP, et al
    HIV-infected patients' beliefs about their chronic co-treatments in comparison with their combined antiretroviral therapy.
    HIV Med. 2017 Aug 16. doi: 10.1111/hiv.12542.
    PubMed     Text format     Abstract available


  70. RAJASINGHAM R, Meya DB, Boulware DR
    Are fluconazole or sertraline dose adjustments necessary with concomitant rifampin?
    HIV Med. 2017 Aug 1. doi: 10.1111/hiv.12543.
    PubMed     Text format    


  71. CAPETTI AF, Di Giambenedetto S, Latini A, Sterrantino G, et al
    Morning dosing for dolutegravir-related insomnia and sleep disorders.
    HIV Med. 2017 Aug 1. doi: 10.1111/hiv.12540.
    PubMed     Text format    


  72. SOODLA P, Simmons R, Huik K, Pauskar M, et al
    HIV incidence in the Estonian population in 2013 determined using the HIV-1 limiting antigen avidity assay.
    HIV Med. 2017 Aug 1. doi: 10.1111/hiv.12535.
    PubMed     Text format     Abstract available


    July 2017
  73. ADETUNJI AA, Kuti MA, Audu RA, Muyibi SA, et al
    Discordant rapid HIV tests: lessons from a low-resource community.
    HIV Med. 2017 Jul 31. doi: 10.1111/hiv.12541.
    PubMed     Text format     Abstract available


  74. SCHEPER H, van Holten N, Hovens J, de Boer M, et al
    Severe depression as a neuropsychiatric side effect induced by dolutegravir.
    HIV Med. 2017 Jul 26. doi: 10.1111/hiv.12538.
    PubMed     Text format    



  75. Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all?
    HIV Med. 2017 Jul 25. doi: 10.1111/hiv.12536.
    PubMed     Text format     Abstract available


  76. GUARALDI G, Malagoli A, Theou O, Brothers TD, et al
    Correlates of frailty phenotype and frailty index and their associations with clinical outcomes.
    HIV Med. 2017 Jul 24. doi: 10.1111/hiv.12527.
    PubMed     Text format     Abstract available


  77. ORKIN C, Llibre JM, Gallien S, Antinori A, et al
    Nucleoside reverse transcriptase inhibitor-reducing strategies in HIV treatment: assessing the evidence.
    HIV Med. 2017 Jul 24. doi: 10.1111/hiv.12534.
    PubMed     Text format     Abstract available


  78. TIRABOSCHI J, Ray S, Patel K, Teague A, et al
    The impact of immunoglobulin in acute HIV infection on the HIV reservoir: a randomized controlled trial.
    HIV Med. 2017 Jul 18. doi: 10.1111/hiv.12524.
    PubMed     Text format     Abstract available


  79. PETT SL, Amin J, Horban A, Andrade-Villanueva J, et al
    Week 96 results of the randomized, multicentre Maraviroc Switch (MARCH) study.
    HIV Med. 2017 Jul 13. doi: 10.1111/hiv.12532.
    PubMed     Text format     Abstract available


  80. JABS AW, Jabs DA, Van Natta ML, Palella FJ, et al
    Insurance status and mortality among patients with AIDS.
    HIV Med. 2017 Jul 11. doi: 10.1111/hiv.12531.
    PubMed     Text format     Abstract available


  81. NANDAR K, Ang LW, Tey J, James L, et al
    Epidemiology of tuberculosis and HIV coinfections in Singapore, 2000-2014.
    HIV Med. 2017 Jul 4. doi: 10.1111/hiv.12529.
    PubMed     Text format     Abstract available


  82. ECHEVERRIA P, Bonjoch A, Puig J, Ornella A, et al
    Significant improvement in triglyceride levels after switching from ritonavir to cobicistat in suppressed HIV-1-infected subjects with dyslipidaemia.
    HIV Med. 2017 Jul 3. doi: 10.1111/hiv.12530.
    PubMed     Text format     Abstract available


  83. CUZIN L, Katlama C, Cotte L, Pugliese P, et al
    Ageing with HIV: do comorbidities and polymedication drive treatment optimization?
    HIV Med. 2017;18:395-401.
    PubMed     Text format     Abstract available


    June 2017
  84. WANG X, Nwokolo N, Korologou-Linden R, Hill A, et al
    InterPrEP: internet-based pre-exposure prophylaxis with generic tenofovir disoproxil fumarate/emtrictabine in London - analysis of pharmacokinetics, safety and outcomes.
    HIV Med. 2017 Jun 28. doi: 10.1111/hiv.12528.
    PubMed     Text format     Abstract available


  85. PROTIERE C, Preau M, Carrieri P, Lambotte O, et al
    Importance of the patient-physician interaction in assessing acceptability of HIV cure trials.
    HIV Med. 2017 Jun 20. doi: 10.1111/hiv.12526.
    PubMed     Text format    


  86. IRELAND G, Ogaz D, Kirwan P, Mandal S, et al
    HIV testing in persons diagnosed with hepatitis B and C.
    HIV Med. 2017 Jun 14. doi: 10.1111/hiv.12525.
    PubMed     Text format    


  87. SAPOZHNIKOV J, Young JD, Patel M, Chiampas TD, et al
    Prevalence of HIV-1 transmitted drug resistance in the incarcerated population.
    HIV Med. 2017 Jun 6. doi: 10.1111/hiv.12522.
    PubMed     Text format     Abstract available


    May 2017
  88. REEVES A, Steele S, Stuckler D, McKee M, et al
    Gender violence, poverty and HIV infection risk among persons engaged in the sex industry: cross-national analysis of the political economy of sex markets in 30 European and Central Asian countries.
    HIV Med. 2017 May 28. doi: 10.1111/hiv.12520.
    PubMed     Text format     Abstract available


  89. ORBAEK M, Thorsteinsson K, Helleberg M, Moseholm E, et al
    Assessment of mode of delivery and predictors of emergency caesarean section among women living with HIV in a matched-pair setting with women from the general population in Denmark, 2002-2014.
    HIV Med. 2017 May 24. doi: 10.1111/hiv.12519.
    PubMed     Text format     Abstract available


  90. HAMPEL B, Kusejko K, Braun DL, Harrison-Quintana J, et al
    Assessing the need for a pre-exposure prophylaxis programme using the social media app Grindr(R).
    HIV Med. 2017 May 19. doi: 10.1111/hiv.12521.
    PubMed     Text format     Abstract available


  91. RIGO F, Cucchetto G, Lanzafame M, Nicole S, et al
    Dual therapy with a combination of unboosted atazanavir and lamivudine as maintenance treatment in virologically suppressed HIV-1-infected patients.
    HIV Med. 2017 May 15. doi: 10.1111/hiv.12523.
    PubMed     Text format    


  92. LEVY ME, Greenberg AE, Hart R, Powers Happ L, et al
    High burden of metabolic comorbidities in a citywide cohort of HIV outpatients: evolving health care needs of people aging with HIV in Washington, DC.
    HIV Med. 2017 May 15. doi: 10.1111/hiv.12516.
    PubMed     Text format     Abstract available


  93. BOMMART S, Cournil A, Eymard-Duvernay S, Raffi F, et al
    Smoking-associated morbidities on computed tomography lung cancer screens in HIV-infected smokers.
    HIV Med. 2017 May 15. doi: 10.1111/hiv.12517.
    PubMed     Text format    


    April 2017
  94. KOENIG HC, Mounzer K, Daughtridge GW, Sloan CE, et al
    Urine assay for tenofovir to monitor adherence in real time to tenofovir disoproxil fumarate/emtricitabine as pre-exposure prophylaxis.
    HIV Med. 2017 Apr 26. doi: 10.1111/hiv.12518.
    PubMed     Text format     Abstract available


  95. BRANNSTROM J, Sonnerborg A, Svedhem V, Neogi U, et al
    A high rate of HIV-1 acquisition post immigration among migrants in Sweden determined by a CD4 T-cell decline trajectory model.
    HIV Med. 2017 Apr 26. doi: 10.1111/hiv.12509.
    PubMed     Text format     Abstract available


  96. TODESCO E, Charpentier C, Bertine M, Wirden M, et al
    Disparities in HIV-1 transmitted drug resistance detected by ultradeep sequencing between men who have sex with men and heterosexual populations.
    HIV Med. 2017 Apr 26. doi: 10.1111/hiv.12508.
    PubMed     Text format     Abstract available


  97. MONNO L, Saracino A, Scudeller L, Santoro C, et al
    Reduced community viral load does not coincide with a reduction in the rate of new HIV diagnoses and recent infections: data from a region of southern Italy.
    HIV Med. 2017 Apr 26. doi: 10.1111/hiv.12515.
    PubMed     Text format     Abstract available


  98. GANTNER P, Cuzin L, Allavena C, Cabie A, et al
    Efficacy and safety of dolutegravir and rilpivirine dual therapy as a simplification strategy: a cohort study.
    HIV Med. 2017 Apr 26. doi: 10.1111/hiv.12506.
    PubMed     Text format    


  99. NEGEDU O, Kim SH, Weston R, Naous N, et al
    Retrospective review of routine clinical patient experiences with dolutegravir; virological suppression, immunological recovery and adverse events.
    HIV Med. 2017 Apr 26. doi: 10.1111/hiv.12510.
    PubMed     Text format    


  100. PATTERSON S, Jose S, Samji H, Cescon A, et al
    A tale of two countries: all-cause mortality among people living with HIV and receiving combination antiretroviral therapy in the UK and Canada.
    HIV Med. 2017 Apr 24. doi: 10.1111/hiv.12505.
    PubMed     Text format     Abstract available


  101. MARZEL A, Shilaih M, Turk T, Campbell NK, et al
    Mining for pairs: shared clinic visit dates identify steady HIV-positive partnerships.
    HIV Med. 2017 Apr 4. doi: 10.1111/hiv.12507.
    PubMed     Text format     Abstract available



  102. Abstracts of the 23rd Annual Conference of the British HIV Association (BHIVA), Liverpool, UK, 4-7 April 2017.
    HIV Med. 2017;18 Suppl 1:3-70.
    PubMed     Text format    


    March 2017
  103. JAMIESON L, Evans D, Brennan AT, Moyo F, et al
    Changes in elevated cholesterol in the era of tenofovir in South Africa: risk factors, clinical management and outcomes.
    HIV Med. 2017 Mar 23. doi: 10.1111/hiv.12495.
    PubMed     Text format     Abstract available


  104. TI L, Dong H, Kerr T, Turje RB, et al
    The effect of engagement in an HIV/AIDS integrated health programme on plasma HIV-1 RNA suppression among HIV-positive people who use illicit drugs: a marginal structural modelling analysis.
    HIV Med. 2017 Mar 19. doi: 10.1111/hiv.12493.
    PubMed     Text format     Abstract available


  105. ERB S, Letang E, Glass TR, Natamatungiro A, et al
    Health care provider communication training in rural Tanzania empowers HIV-infected patients on antiretroviral therapy to discuss adherence problems.
    HIV Med. 2017 Mar 13. doi: 10.1111/hiv.12499.
    PubMed     Text format     Abstract available


  106. MONROE AK, Zhang L, Jacobson LP, Plankey MW, et al
    The association between physical activity and cognition in men with and without HIV infection.
    HIV Med. 2017 Mar 13. doi: 10.1111/hiv.12490.
    PubMed     Text format     Abstract available


  107. BROWN J, McGowan JA, Chouial H, Capocci S, et al
    Respiratory health status is impaired in UK HIV-positive adults with virologically suppressed HIV infection.
    HIV Med. 2017 Mar 13. doi: 10.1111/hiv.12497.
    PubMed     Text format     Abstract available


  108. SOCIAS ME, Ti L, Dong H, Shoveller J, et al
    High prevalence of willingness to use direct-acting antiviral-based regimens for hepatitis C virus (HCV) infection among HIV/HCV coinfected people who use drugs.
    HIV Med. 2017 Mar 13. doi: 10.1111/hiv.12501.
    PubMed     Text format     Abstract available


  109. GEBRESELASSIE HM, Kraus D, Fux CA, Haubitz S, et al
    Ethnicity predicts viral rebound after travel to the tropics in HIV-infected travelers to the tropics in the Swiss HIV Cohort Study.
    HIV Med. 2017 Mar 1. doi: 10.1111/hiv.12491.
    PubMed     Text format     Abstract available


  110. PAYNE B, Chadwick TJ, Blamire A, Anderson KN, et al
    Does efavirenz replacement improve neurological function in treated HIV infection?
    HIV Med. 2017 Mar 1. doi: 10.1111/hiv.12503.
    PubMed     Text format     Abstract available


  111. TRON L, Lert F, Spire B, Dray-Spira R, et al
    Levels and determinants of breast and cervical cancer screening uptake in HIV-infected women compared with the general population in France.
    HIV Med. 2017;18:181-195.
    PubMed     Text format     Abstract available


    February 2017
  112. MENA A, Meijide H, Rodriguez-Osorio I, Castro A, et al
    Liver-related mortality and hospitalizations attributable to chronic hepatitis C virus coinfection in persons living with HIV.
    HIV Med. 2017 Feb 23. doi: 10.1111/hiv.12502.
    PubMed     Text format     Abstract available


  113. WANG Z, Wu X, Lau J, Mo P, et al
    Prevalence of and factors associated with unprotected anal intercourse with regular and nonregular male sexual partners among newly diagnosed HIV-positive men who have sex with men in China.
    HIV Med. 2017 Feb 23. doi: 10.1111/hiv.12500.
    PubMed     Text format     Abstract available


  114. PUHR R, Petoumenos K, Youds D, Law MG, et al
    The impact of changes in HIV management guidelines on time to treatment initiation in Australia.
    HIV Med. 2017 Feb 22. doi: 10.1111/hiv.12504.
    PubMed     Text format    


  115. RALLON N, Restrepo C, Vicario JL, Del Romero J, et al
    Human leucocyte antigen (HLA)-DQB1*03:02 and HLA-A*02:01 have opposite patterns in their effects on susceptibility to HIV infection.
    HIV Med. 2017 Feb 20. doi: 10.1111/hiv.12494.
    PubMed     Text format     Abstract available


  116. WILLIAMS C
    Response to Glinka et al. "Timing matters - influenza vaccination to HIV-infected patients".
    HIV Med. 2017 Feb 16. doi: 10.1111/hiv.12485.
    PubMed     Text format    


  117. MANCINELLI S, Nielsen-Saines K, Germano P, Guidotti G, et al
    Who will be lost? Identifying patients at risk of loss to follow-up in Malawi. The DREAM Program Experience.
    HIV Med. 2017 Feb 2. doi: 10.1111/hiv.12492.
    PubMed     Text format     Abstract available


  118. GALLIEN S, Journot V, Loriot MA, Sauvageon H, et al
    Cytochrome 2B6 polymorphism and efavirenz-induced central nervous system symptoms : a substudy of the ANRS ALIZE trial.
    HIV Med. 2017 Feb 1. doi: 10.1111/hiv.12488.
    PubMed     Text format     Abstract available


    January 2017
  119. SERNA-OJEDA JC, Navas A, Graue-Hernandez EO
    Smaller needles, lower risks?: Occupational HIV risk for healthcare professionals.
    HIV Med. 2017 Jan 27. doi: 10.1111/hiv.12496.
    PubMed     Text format    


  120. DESAI S, Nardone A, Hughes G, Delpech V, et al
    HIV incidence in an open national cohort of men who have sex with men attending sexually transmitted infection clinics in England.
    HIV Med. 2017 Jan 27. doi: 10.1111/hiv.12498.
    PubMed     Text format     Abstract available


  121. ELLIOT ER, Singh S, Tyebally S, Gedela K, et al
    Recreational drug use and chemsex among HIV-infected in-patients: a unique screening opportunity.
    HIV Med. 2017 Jan 24. doi: 10.1111/hiv.12487.
    PubMed     Text format     Abstract available


  122. CRESSWELL FV, Levett T
    Specialist care of older adults with HIV infection in the UK: a service evaluation.
    HIV Med. 2017 Jan 24. doi: 10.1111/hiv.12481.
    PubMed     Text format     Abstract available


  123. DREW RS, Rice B, Ruutel K, Delpech V, et al
    HIV continuum of care in Europe and Central Asia.
    HIV Med. 2017 Jan 24. doi: 10.1111/hiv.12480.
    PubMed     Text format     Abstract available


  124. YOUSSEF E, Cooper V, Nixon E, Vera JH, et al
    The management of comorbidities in older people living with HIV in England: a cross sectional survey.
    HIV Med. 2017 Jan 24. doi: 10.1111/hiv.12484.
    PubMed     Text format    


  125. CALZA L, Colangeli V, Magistrelli E, Bussini L, et al
    Plasma trough concentrations of darunavir/ritonavir and raltegravir in older patients with HIV-1 infection.
    HIV Med. 2017 Jan 24. doi: 10.1111/hiv.12478.
    PubMed     Text format     Abstract available


  126. NUNEZ-TORRES R, Macias J, Rivero-Juarez A, Neukam K, et al
    Fat mass and obesity-associated gene variations are related to fatty liver disease in HIV-infected patients.
    HIV Med. 2017 Jan 24. doi: 10.1111/hiv.12489.
    PubMed     Text format     Abstract available


  127. GLINKA ER, Smith DM, Johns ST
    Now is the Time to Study the Timing of Influenza Vaccine.
    HIV Med. 2017 Jan 24. doi: 10.1111/hiv.12486.
    PubMed     Text format    


  128. O'LAUGHLIN KN, Kasozi J, Rabideau DJ, Parker RA, et al
    The cascade of HIV care among refugees and nationals in Nakivale Refugee Settlement in Uganda.
    HIV Med. 2017 Jan 10. doi: 10.1111/hiv.12476.
    PubMed     Text format     Abstract available


  129. NOY M, Merika EE, Morar N, Nelson M, et al
    aSKINg advice-the need for specialist dermatologists in HIV units.
    HIV Med. 2017;18:64-65.
    PubMed     Text format    


  130. MADGE S, Smith C, Warren-Gash C, Bayly J, et al
    Screening for intimate partner violence in a London HIV clinic: characteristics of those screening positive.
    HIV Med. 2017;18:66-68.
    PubMed     Text format    


    December 2016
  131. SORIANO-ARANDES A, Noguera-Julian A, Fortuny C
    Impact of immigration on HIV mother-to-child transmission in Western Europe.
    HIV Med. 2016 Dec 30. doi: 10.1111/hiv.12482.
    PubMed     Text format    


  132. POVEDA E, Hernandez-Quero J, Perez-Elias MJ, Ribas MA, et al
    Genotypic tropism testing of proviral DNA to guide maraviroc initiation in aviraemic subjects: 48-week analysis of results from the PROTEST study.
    HIV Med. 2016 Dec 30. doi: 10.1111/hiv.12479.
    PubMed     Text format     Abstract available


  133. HARRISON N, Poeppl W, Herkner H, Tillhof KD, et al
    Predictors for and coverage of influenza vaccination among HIV-positive patients: a cross-sectional survey.
    HIV Med. 2016 Dec 30. doi: 10.1111/hiv.12483.
    PubMed     Text format     Abstract available


  134. SEWELL J, Daskalopoulou M, Nakagawa F, Lampe FC, et al
    Accuracy of self-report of HIV viral load among people with HIV on antiretroviral treatment.
    HIV Med. 2016 Dec 22. doi: 10.1111/hiv.12477.
    PubMed     Text format     Abstract available


  135. KUMAR P, Lakshmi YS, Kondapi AK
    An oral formulation of efavirenz-loaded lactoferrin nanoparticles with improved biodistribution and pharmacokinetic profile.
    HIV Med. 2016 Dec 21. doi: 10.1111/hiv.12475.
    PubMed     Text format     Abstract available


  136. FLORIDIA M, Tamburrini E, Masuelli G, Martinelli P, et al
    Rate, correlates and outcomes of repeat pregnancy in HIV-infected women.
    HIV Med. 2016 Dec 21. doi: 10.1111/hiv.12473.
    PubMed     Text format     Abstract available


  137. CHADWICK DR, Hall C, Rae C, Rayment M, et al
    A feasibility study for a clinical decision support system prompting HIV testing.
    HIV Med. 2016 Dec 21. doi: 10.1111/hiv.12472.
    PubMed     Text format     Abstract available


  138. HENRIQUEZ-CAMACHO C, Villafuerte-Gutierrez P, Perez-Molina JA, Losa J, et al
    Opt-out screening strategy for HIV infection among patients attending emergency departments: systematic review and meta-analysis.
    HIV Med. 2016 Dec 21. doi: 10.1111/hiv.12474.
    PubMed     Text format     Abstract available


  139. JIN C, Cheng L, Hoxtermann S, Xie T, et al
    MicroRNA-155 is a biomarker of T-cell activation and immune dysfunction in HIV-1-infected patients.
    HIV Med. 2016 Dec 16. doi: 10.1111/hiv.12470.
    PubMed     Text format     Abstract available


  140. FRASER-TALIENTE T, Mackie NE, Kaye S, Nyirenda M, et al
    Off-licence use of once-daily maraviroc in children and adolescents with perinatally acquired HIV-1 infection.
    HIV Med. 2016 Dec 16. doi: 10.1111/hiv.12467.
    PubMed     Text format    


    November 2016
  141. MACIAS J, Monge P, Mancebo M, Merchante N, et al
    High frequency of potential interactions between direct-acting antivirals and concomitant therapy in HIV/hepatitis C virus-coinfected patients in clinical practice.
    HIV Med. 2016 Nov 24. doi: 10.1111/hiv.12471.
    PubMed     Text format     Abstract available


  142. TOWNSEND CL, de Ruiter A, Peters H, Nelson-Piercy C, et al
    Pregnancies in older women living with HIV in the UK and Ireland.
    HIV Med. 2016 Nov 16. doi: 10.1111/hiv.12469.
    PubMed     Text format     Abstract available


  143. HOFFMANN C, Welz T, Sabranski M, Kolb M, et al
    Higher rates of neuropsychiatric adverse events leading to dolutegravir discontinuation in women and older patients.
    HIV Med. 2016 Nov 10. doi: 10.1111/hiv.12468.
    PubMed     Text format     Abstract available


  144. WEBEL AR, Sattar A, Funderburg NT, Kinley B, et al
    Alcohol and dietary factors associate with gut integrity and inflammation in HIV-infected adults.
    HIV Med. 2016 Nov 9. doi: 10.1111/hiv.12442.
    PubMed     Text format     Abstract available



  145. A note of thanks to referees for Volume 17, 2016.
    HIV Med. 2016;17:778-780.
    PubMed     Text format    



  146. Erratum.
    HIV Med. 2016;17:781.
    PubMed     Text format    


    October 2016
  147. UNDERWOOD J, De Francesco D, Post FA, Vera JH, et al
    Associations between cognitive impairment and patient-reported measures of physical/mental functioning in older people living with HIV.
    HIV Med. 2016 Oct 26. doi: 10.1111/hiv.12434.
    PubMed     Text format     Abstract available


  148. GRINT D, Tedaldi E, Peters L, Mocroft A, et al
    Hepatitis C virus (HCV) RNA profiles among chronic HIV/HCV-coinfected individuals in ESPRIT; spontaneous HCV RNA clearance observed in nine individuals.
    HIV Med. 2016 Oct 26. doi: 10.1111/hiv.12466.
    PubMed     Text format     Abstract available


  149. FERRAIOLI G
    The clinical value of the controlled attenuation parameter in the follow-up of HIV-infected patients.
    HIV Med. 2016 Oct 4. doi: 10.1111/hiv.12443.
    PubMed     Text format    


  150. ST-JEAN M, Harrigan PR, Sereda P, Montaner J, et al
    An assessment of the relationship between the World Health Organization HIV drug resistance early warning indicators and HIV drug resistance acquisition.
    HIV Med. 2016 Oct 4. doi: 10.1111/hiv.12435.
    PubMed     Text format     Abstract available


  151. MODY N, Nixon E, Buckingham T, Churchill D, et al
    It's the quality that counts: audit of the quality of transfer information for patients moving their HIV care between units.
    HIV Med. 2016;17:708.
    PubMed     Text format    


  152. RAFFI F, Esser S, Nunnari G, Perez-Valero I, et al
    Switching regimens in virologically suppressed HIV-1-infected patients: evidence base and rationale for integrase strand transfer inhibitor (INSTI)-containing regimens.
    HIV Med. 2016;17 Suppl 5:3-16.
    PubMed     Text format     Abstract available


    September 2016
  153. CANAN CE, Lau B, McCaul ME, Keruly J, et al
    Effect of alcohol consumption on all-cause and liver-related mortality among HIV-infected individuals.
    HIV Med. 2016 Sep 28. doi: 10.1111/hiv.12433.
    PubMed     Text format     Abstract available


  154. LENG CY, Low HC, Chua LL, Chong ML, et al
    Human papillomavirus 16 (HPV16) and HPV52 E6-specific immunity in HIV-infected adults on combination antiretroviral therapy.
    HIV Med. 2016 Sep 20. doi: 10.1111/hiv.12432.
    PubMed     Text format     Abstract available


  155. FEUILLET P, Lert F, Tron L, Aubriere C, et al
    Prevalence of and factors associated with depression among people living with HIV in France.
    HIV Med. 2016 Sep 14. doi: 10.1111/hiv.12438.
    PubMed     Text format     Abstract available


  156. JUDD A, Lodwick R, Noguera-Julian A, Gibb DM, et al
    Higher rates of triple-class virological failure in perinatally HIV-infected teenagers compared with heterosexually infected young adults in Europe.
    HIV Med. 2016 Sep 14. doi: 10.1111/hiv.12411.
    PubMed     Text format     Abstract available


  157. BOUTELOUP V, Sabin C, Mocroft A, Gras L, et al
    Reference curves for CD4 T-cell count response to combination antiretroviral therapy in HIV-1-infected treatment-naive patients.
    HIV Med. 2016 Sep 14. doi: 10.1111/hiv.12389.
    PubMed     Text format     Abstract available


  158. ZHONG F, Tang W, Cheng W, Lin P, et al
    Acceptability and feasibility of a social entrepreneurship testing model to promote HIV self-testing and linkage to care among men who have sex with men.
    HIV Med. 2016 Sep 7. doi: 10.1111/hiv.12437.
    PubMed     Text format     Abstract available


  159. MODY N, Perry N, Richardson D, Barbour L, et al
    Routine HIV testing in acute hospital admissions.
    HIV Med. 2016;17:634.
    PubMed     Text format    


    August 2016
  160. TEERAANANCHAI S, Kerr SJ, Amin J, Ruxrungtham K, et al
    Life expectancy of HIV-positive people after starting combination antiretroviral therapy: a meta-analysis.
    HIV Med. 2016 Aug 31. doi: 10.1111/hiv.12421.
    PubMed     Text format     Abstract available


  161. KOWALSKA JD, Oprea C, de Witt S, Pozniak A, et al
    Euroguidelines in Central and Eastern Europe (ECEE) conference and the Warsaw Declaration - a comprehensive meeting report.
    HIV Med. 2016 Aug 24. doi: 10.1111/hiv.12436.
    PubMed     Text format     Abstract available


  162. NADEL J, Holloway CJ
    Screening and risk assessment for coronary artery disease in HIV infection: an unmet need.
    HIV Med. 2016 Aug 24. doi: 10.1111/hiv.12422.
    PubMed     Text format     Abstract available


  163. ZHANG X, Tang W, Li Y, Mahapatra T, et al
    The HIV/AIDS epidemic among young people in China between 2005 and 2012: results of a spatial temporal analysis.
    HIV Med. 2016 Aug 24. doi: 10.1111/hiv.12408.
    PubMed     Text format     Abstract available


  164. GISSLEN M, Svedhem V, Lindborg L, Flamholc L, et al
    Sweden, the first country to achieve the Joint United Nations Programme on HIV/AIDS (UNAIDS)/World Health Organization (WHO) 90-90-90 continuum of HIV care targets.
    HIV Med. 2016 Aug 18. doi: 10.1111/hiv.12431.
    PubMed     Text format     Abstract available


  165. LORD E, Stockdale AJ, Malek R, Rae C, et al
    Evaluation of HIV testing recommendations in specialty guidelines for the management of HIV indicator conditions.
    HIV Med. 2016 Aug 18. doi: 10.1111/hiv.12430.
    PubMed     Text format     Abstract available


  166. HOWARTH AR, Burns FM, Apea V, Jose S, et al
    Development and application of a new measure of engagement in out-patient HIV care.
    HIV Med. 2016 Aug 18. doi: 10.1111/hiv.12427.
    PubMed     Text format     Abstract available


  167. KHADEMI N, Reshadat S, Zangeneh A, Saeidi S, et al
    A comparative study of the spatial distribution of HIV prevalence in the metropolis of Kermanshah, Iran, in 1996-2014 using geographical information systems.
    HIV Med. 2016 Aug 18. doi: 10.1111/hiv.12416.
    PubMed     Text format     Abstract available


  168. SILVA-PINTO A, Costa A, Serrao R, Sarmento A, et al
    Ischaemic stroke in HIV-infected patients: a case-control study.
    HIV Med. 2016 Aug 18. doi: 10.1111/hiv.12415.
    PubMed     Text format     Abstract available


  169. FLOWERS P, Riddell J, Park C, Ahmed B, et al
    Preparedness for use of the rapid result HIV self-test by gay men and other men who have sex with men (MSM): a mixed methods exploratory study among MSM and those involved in HIV prevention and care.
    HIV Med. 2016 Aug 5. doi: 10.1111/hiv.12420.
    PubMed     Text format     Abstract available


  170. DO TC, Boettiger D, Law M, Pujari S, et al
    Smoking and projected cardiovascular risk in an HIV-positive Asian regional cohort.
    HIV Med. 2016;17:542-9.
    PubMed     Text format     Abstract available


  171. TOMINSKI D, Katchanov J, Driesch D, Daley MB, et al
    The late-presenting HIV-infected patient 30 years after the introduction of HIV testing: spectrum of opportunistic diseases and missed opportunities for early diagnosis.
    HIV Med. 2016 Aug 1. doi: 10.1111/hiv.12403.
    PubMed     Text format     Abstract available


  172. LIN SY, Lachowsky NJ, Hull M, Rich A, et al
    Awareness and use of nonoccupational post-exposure prophylaxis among men who have sex with men in Vancouver, Canada.
    HIV Med. 2016 Aug 1. doi: 10.1111/hiv.12369.
    PubMed     Text format     Abstract available


  173. MILAZZO L, Lai A, Calvi E, Ronzi P, et al
    Direct-acting antivirals in hepatitis C virus (HCV)-infected and HCV/HIV-coinfected patients: real-life safety and efficacy.
    HIV Med. 2016 Aug 1. doi: 10.1111/hiv.12429.
    PubMed     Text format     Abstract available


  174. KRIKKE M, Arends JE, Van Lelyveld S, Hoepelman A, et al
    Greater carotid intima media thickness at a younger age in HIV-infected patients compared with reference values for an uninfected cohort.
    HIV Med. 2016 Aug 1. doi: 10.1111/hiv.12428.
    PubMed     Text format     Abstract available


  175. ROJAS CASTRO D, Quatremere G, Sagaon-Teyssier L, Le Gall JM, et al
    Informal pre-exposure prophylaxis use in France: results from the Flash PrEP survey (2014).
    HIV Med. 2016 Aug 1. doi: 10.1111/hiv.12419.
    PubMed     Text format    


  176. SUDJARITRUK T, Bunupuradah T, Aurpibul L, Kosalaraksa P, et al
    Adverse bone health and abnormal bone turnover among perinatally HIV-infected Asian adolescents with virological suppression.
    HIV Med. 2016 Aug 1. doi: 10.1111/hiv.12418.
    PubMed     Text format     Abstract available


  177. IMAZ A, Niubo J, Kashuba AD, Ferrer E, et al
    Elvitegravir concentrations in seminal plasma in HIV-1-infected men.
    HIV Med. 2016 Aug 1. doi: 10.1111/hiv.12417.
    PubMed     Text format     Abstract available


  178. TOSTEVIN A, White E, Dunn D, Croxford S, et al
    Recent trends and patterns in HIV-1 transmitted drug resistance in the United Kingdom.
    HIV Med. 2016 Aug 1. doi: 10.1111/hiv.12414.
    PubMed     Text format     Abstract available


  179. TEIRA R, Vidal F, Munoz-Sanchez P, Geijo P, et al
    Very low level viraemia and risk of virological failure in treated HIV-1-infected patients.
    HIV Med. 2016 Aug 1. doi: 10.1111/hiv.12413.
    PubMed     Text format     Abstract available


  180. FRENCH CE, Thorne C, Byrne L, Cortina-Borja M, et al
    Presentation for care and antenatal management of HIV in the UK, 2009-2014.
    HIV Med. 2016 Aug 1. doi: 10.1111/hiv.12410.
    PubMed     Text format     Abstract available


  181. CHURCHILL D, Waters L, Ahmed N, Angus B, et al
    British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015.
    HIV Med. 2016;17 Suppl 4:s2-s104.
    PubMed     Text format    


  182. GERETTI AM, Brook G, Cameron C, Chadwick D, et al
    British HIV Association Guidelines on the Use of Vaccines in HIV-Positive Adults 2015.
    HIV Med. 2016;17 Suppl 3:s2-s81.
    PubMed     Text format    


    July 2016
  183. MCGOWAN JA, Sherr L, Rodger AJ, Fisher M, et al
    Age, time living with diagnosed HIV infection, and self-rated health.
    HIV Med. 2016 Jul 7. doi: 10.1111/hiv.12398.
    PubMed     Text format     Abstract available


  184. KESSELRING S, Cescon A, Colley G, Osborne C, et al
    Quality of initial HIV care in Canada: extension of a composite programmatic assessment tool for HIV therapy.
    HIV Med. 2016 Jul 6. doi: 10.1111/hiv.12409.
    PubMed     Text format     Abstract available


  185. FOSTER C, Bamford A, Turkova A, Welch S, et al
    Paediatric European Network for Treatment of AIDS Treatment Guideline 2016 update: antiretroviral therapy recommended for all children living with HIV.
    HIV Med. 2016 Jul 6. doi: 10.1111/hiv.12399.
    PubMed     Text format    


  186. POST FA, Yombi JC, Hougardy JM
    Monitoring of kidney function in older people living with HIV.
    HIV Med. 2016 Jul 6. doi: 10.1111/hiv.12396.
    PubMed     Text format    


  187. MUSSO CG, Belloso WH
    Monitoring of kidney function in elderly HIV-positive patients.
    HIV Med. 2016 Jul 6. doi: 10.1111/hiv.12395.
    PubMed     Text format    


    June 2016
  188. HERNANDEZ AV, Thota P, Pellegrino D, Pasupuleti V, et al
    A systematic review and meta-analysis of the relative efficacy and safety of treatment regimens for HIV-associated cerebral toxoplasmosis: is trimethoprim-sulfamethoxazole a real option?
    HIV Med. 2016 Jun 28. doi: 10.1111/hiv.12402.
    PubMed     Text format     Abstract available


  189. ROSSOUW TM, Nieuwoudt M, Manasa J, Malherbe G, et al
    HIV drug resistance levels in adults failing first-line antiretroviral therapy in an urban and a rural setting in South Africa.
    HIV Med. 2016 Jun 28. doi: 10.1111/hiv.12400.
    PubMed     Text format     Abstract available


  190. MYER L, Phillips TK, McIntyre JA, Hsiao NY, et al
    HIV viraemia and mother-to-child transmission risk after antiretroviral therapy initiation in pregnancy in Cape Town, South Africa.
    HIV Med. 2016 Jun 28. doi: 10.1111/hiv.12397.
    PubMed     Text format     Abstract available


  191. ARMENIA D, Di Carlo D, Maffongelli G, Borghi V, et al
    Virological response and resistance profile in HIV-1-infected patients starting darunavir-containing regimens.
    HIV Med. 2016 Jun 28. doi: 10.1111/hiv.12388.
    PubMed     Text format     Abstract available


  192. LI M, Foli Y, Liu Z, Wang G, et al
    High frequency of mitochondrial DNA mutations in HIV-infected treatment-experienced individuals.
    HIV Med. 2016 Jun 22. doi: 10.1111/hiv.12390.
    PubMed     Text format     Abstract available


  193. GIRARD PM, Antinori A, Arribas JR, Ripamonti D, et al
    Week 96 efficacy and safety of darunavir/ritonavir monotherapy vs. darunavir/ritonavir with two nucleoside reverse transcriptase inhibitors in the PROTEA trial.
    HIV Med. 2016 Jun 9. doi: 10.1111/hiv.12386.
    PubMed     Text format     Abstract available


  194. CHEUNG CC, Ding E, Sereda P, Yip B, et al
    Reductions in all-cause and cause-specific mortality among HIV-infected individuals receiving antiretroviral therapy in British Columbia, Canada: 2001-2012.
    HIV Med. 2016 Jun 9. doi: 10.1111/hiv.12379.
    PubMed     Text format     Abstract available


  195. SANCHEZ-GONZALEZ G
    The cost-effectiveness of treating triple coinfection with HIV, tuberculosis and hepatitis C virus.
    HIV Med. 2016 Jun 9. doi: 10.1111/hiv.12372.
    PubMed     Text format     Abstract available


  196. VIDELA S, Sirera G, Ornelas A, Pinol M, et al
    Incidence of squamous intraepithelial lesions in the anal canal of HIV-infected men with normal cytology, up to 8 years of follow-up.
    HIV Med. 2016;17:479-81.
    PubMed     Text format    


    May 2016
  197. CRAUWELS HM, Kakuda TN, Ryan B, Zorrilla C, et al
    Pharmacokinetics of once-daily darunavir/ritonavir in HIV-1-infected pregnant women.
    HIV Med. 2016 May 17. doi: 10.1111/hiv.12366.
    PubMed     Text format     Abstract available


  198. SHMAGEL KV, Saidakova EV, Shmagel NG, Korolevskaya LB, et al
    Systemic inflammation and liver damage in HIV/hepatitis C virus coinfection.
    HIV Med. 2016 May 17. doi: 10.1111/hiv.12357.
    PubMed     Text format     Abstract available


  199. MICHEL L, Lions C, Winnock M, Lang JP, et al
    Psychiatric and substance use disorders in HIV/hepatitis C virus (HCV)-coinfected patients: does HCV clearance matter? [Agence Nationale de Recherche sur le SIDA et les Hepatites Virales (ANRS) HEPAVIH CO13 cohort].
    HIV Med. 2016 May 17. doi: 10.1111/hiv.12382.
    PubMed     Text format     Abstract available


  200. RODKJAER L, Gabel C, Laursen T, Slot M, et al
    Simple and practical screening approach to identify HIV-infected individuals with depression or at risk of developing depression.
    HIV Med. 2016 May 17. doi: 10.1111/hiv.12381.
    PubMed     Text format     Abstract available


  201. SELLIER P, Ostertag A, Collet C, Trout H, et al
    Disrupted trabecular bone micro-architecture in middle-aged male HIV-infected treated patients.
    HIV Med. 2016 May 17. doi: 10.1111/hiv.12380.
    PubMed     Text format     Abstract available


  202. EDELMAN EJ, Gordon KS, Tate JP, Becker WC, et al
    The impact of prescribed opioids on CD4 cell count recovery among HIV-infected patients newly initiating antiretroviral therapy.
    HIV Med. 2016 May 17. doi: 10.1111/hiv.12377.
    PubMed     Text format     Abstract available


  203. SIMMONS R, Kall M, Collins S, Cairns G, et al
    A global survey of HIV-positive people's attitudes towards cure research.
    HIV Med. 2016 May 11. doi: 10.1111/hiv.12391.
    PubMed     Text format     Abstract available


  204. FATKENHEUER G, Jessen H, Stoehr A, Jung N, et al
    PEPDar: A randomized prospective noninferiority study of ritonavir-boosted darunavir for HIV post-exposure prophylaxis.
    HIV Med. 2016 May 11. doi: 10.1111/hiv.12363.
    PubMed     Text format     Abstract available


  205. PASTORI D, Esposito A, Carnevale R, Bartimoccia S, et al
    Short-term in vivo modifications of platelet NADPH oxidase 2 (NOX2) and prostaglandin F in HIV-1 patients on abacavir-based therapies.
    HIV Med. 2016 May 10. doi: 10.1111/hiv.12383.
    PubMed     Text format     Abstract available


  206. MUTIMURA E, Shi Q, Hoover DR, Anastos K, et al
    Bone quality assessed using quantitative ultrasound at the distal radius does not differ in antiretroviral therapy-naive HIV-positive and HIV-negative Rwandan women.
    HIV Med. 2016 May 10. doi: 10.1111/hiv.12376.
    PubMed     Text format     Abstract available


    September 2015
  207. ROUGEMONT M, Nchotu Ngang P, Stoll B, Delhumeau C, et al
    Safety of zidovudine dose reduction in treatment-naive HIV infected patients. A randomized controlled study (MiniZID).
    HIV Med. 2015 Sep 10. doi: 10.1111/hiv.12303.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: